33 completed, 9 active not recruiting, 8 terminated, 7 recruiting. 64 Phase 1, 29 Phase 2.
Follow Thalassemia: new trials by email Literature Review of Thalassemia trials Research Report on Thalassemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors Total Body Irradiation, Alemtuzumab, Abatacept - Sickle Cell Disease, Beta-thalassemia | Phase 1 / Phase 2 | Recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 90 | 2026-07-08 | 2026-10-13 |
| Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease Pociredir - Sickle Cell Disease | Phase 1 | Terminated | Fulcrum Therapeutics | 13 | 2025-12-13 | 2026-06-18 |
| Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies autologous bone marrow derived CD34+ HSPCs electroporated with BCL11A enhancer targeting Cas9 ribonucleoprotein, Sequencing Assay for Variant rs114518452 - Sickle Cell Disease, Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) | Phase 1 | Recruiting | Daniel Bauer | 10 | 2025-12-01 | 2026-02-03 |
| A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants Etavopivat, Moxifloxacin, Placebo - Healthy Volunteers, Sickle Cell Disease | Phase 1 | Completed | Novo Nordisk A/S | 33 | 2025-06-09 | 2026-01-02 |
| ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia ALS20 - Beta-Thalassemia | Phase 1 / Phase 2 | Active not recruiting | Children's Hospital of Philadelphia | 12 | 2025-04-14 | 2026-10-29 |
| A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants Etavopivat, Digoxin, Pitavastatin - Healthy Volunteers Sickle Cell Disease, Thalassemia | Phase 1 | Completed | Novo Nordisk A/S | 37 | 2025-02-06 | 2026-09-29 |
| A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia 9MW3011, 9MW3011 placebo - Beta-Thalassemia | Phase 1 | Recruiting | Mabwell (Shanghai) Bioscience Co., Ltd. | 40 | 2024-12-30 | 2025-01-14 |
| A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants Etavopivat - Healthy Volunteers, Sickle Cell Disease | Phase 1 | Completed | Novo Nordisk A/S | 24 | 2024-08-26 | 2025-12-29 |
| Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients. β-globin restored autologous hematopoietic stem cells - Β-thalassemia | Phase 1 | Recruiting | Shenzhen Hemogen | 8 | 2024-06-12 | 2024-10-23 |
| A Research Study of the Effect of Food on Etavopivat in Healthy Participants Etavopivat - Healthy Volunteers Sickle Cell Disease, Thalassemia | Phase 1 | Completed | Novo Nordisk A/S | 16 | 2024-05-28 | 2025-10-10 |
| An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia Vebeglogene autotemcel - Beta-Thalassemia | Phase 1 / Phase 2 | Active not recruiting | Lantu Biopharma | 6 | 2024-05-11 | 2026-06-15 |
| A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major CS-101 injection - Beta-Thalassemia Major | Phase 1 | Completed | CorrectSequence Therapeutics Co., Ltd | 9 | 2024-04-18 | 2026-02-10 |
| NAC Effect on Iron Overload and Blood Transfusion in β-thalassemia Major n-acetylcystine - Thalassemia Major | Phase 1 | Unknown | Assiut University | 100 | 2024-03-23 | 2023-08-23 |
| Safety & Efficacy of Thalidomide in Children With Transfusion Dependent Thalassemia Thalidomide Capsules, Placebo - Transfusion-dependent Thalassemia | Phase 1 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 60 | 2023-03-01 | 2024-04-09 |
| Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia BRL-101 - Beta-Thalassemia | Phase 1 / Phase 2 | Active not recruiting | Bioray Laboratories | 39 | 2022-11-02 | 2026-07-21 |
| Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia TBI, Hydroxyurea, briquilimab - Sickle Cell Anemia, Beta Thalassemia | Phase 1 / Phase 2 | Active not recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 40 | 2022-05-12 | 2026-03-12 |
| EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) EDIT-301 - Transfusion Dependent Beta Thalassemia, Hemoglobinopathies | Phase 1 / Phase 2 | Active not recruiting | Editas Medicine, Inc. | 9 | 2022-04-29 | 2025-04-02 |
| Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia Abatacept, Sirolimus - Thalassemia in Children | Phase 1 / Phase 2 | Recruiting | The Hospital for Sick Children | 20 | 2022-03-22 | 2023-12-19 |
| A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia ET-01 - Transfusion Dependent Beta-Thalassaemia | Phase 1 | Terminated | EdiGene (GuangZhou) Inc. | 8 | 2021-08-17 | 2025-03-30 |
| The BENeFiTS Trial in Beta Thalassemia Intermedia Benserazide Only Product - Beta Thalassemia Intermedia, Sickle Cell Disease | Phase 1 / Phase 2 | Enrolling by invitation | Phoenicia BioScience | 36 | 2020-10-05 | 2025-08-15 |
Showing 20 of 64. Sign in to see all of them.
beta-Thalassemia (35) · Anemia, Sickle Cell (31) · Hemoglobinopathies (9) · Anemia, Diamond-Blackfan (8) · Anemia (6) · Anemia, Aplastic (4) · Fanconi Anemia (4) · Granulomatous Disease, Chronic (4) · Iron Overload (4) · Mucopolysaccharidosis I (4) · Genetic Diseases, Inborn (3) · Hemoglobin SC Disease (3) · Lymphohistiocytosis, Hemophagocytic (3) · Myelodysplastic Syndromes (3)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (64) · Hemic and Lymphatic Diseases (64) · Anemia, Hemolytic (62) · Anemia, Hemolytic, Congenital (62) · Hematologic Diseases (62) · Genetic Diseases, Inborn (61) · Anemia (58) · Hemoglobinopathies (55) · Nutritional and Metabolic Diseases (11) · Metabolic Diseases (10) · Bone Marrow Diseases (9) · Immune System Diseases (9) · Anemia, Hypoplastic, Congenital (8) · Red-Cell Aplasia, Pure (8)
Alemtuzumab (7) · Sirolimus (5) · Hydroxyurea (4) · Abatacept (3) · fludarabine (3) · AP 1903 reagent (2) · Cyclophosphamide (2) · Deferasirox (2) · Deferoxamine (2) · Hematopoietic Stem Cell Transplantation (2) · Melphalan (2) · Mycophenolic Acid (2) · Tacrolimus (2) · Thiotepa (2) · 2,2-dimethylbutyric acid (1)
National Heart, Lung, and Blood Institute (NHLBI) (6) · Novo Nordisk A/S (4) · Bellicum Pharmaceuticals (3) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3) · Children's Hospital of Philadelphia (2) · Gamida Cell ltd (2) · Hangzhou Zede Pharma-Tech Co., Ltd. (2) · Abdullah Kutlar (1) · Assiut University (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Beni-Suef University (1) · Bioray Laboratories (1) · Catherine Bollard (1) · Celgene (1) · Children's Hospital Los Angeles (1)
United States (39) · China (10) · Canada (5) · Thailand (4) · Italy (3) · Australia (2) · France (2) · Lebanon (2) · United Kingdom (2) · Bangladesh (1) · Egypt (1) · Iran (1) · Jamaica (1) · Singapore (1) · Turkey (Türkiye) (1)
John F Tisdale, M.D. (4) · Abdullah Kutlar, MD (1) · Alessandro Aiuti, MD, PhD (1) · Allistair Abraham, MD (1) · Angela E Rankine- Mullings, MD (1) · Biljana Horn, MD (1) · Chao Liu, PHD (1) · Courtney D Fitzhugh, M.D. (1) · Ellis Neufeld, MD (1) · Erica Esrick, MD (1) · Fabio Ciceri, MD (1)
PMID 36240296, PMID 42133908, PMID 17536019, PMID 17620452, PMID 18439858, PMID 20007560, PMID 21742281, PMID 22875626, PMID 24296492, PMID 24916507, PMID 25058217, PMID 25222041, PMID 25938131, PMID 26348869, PMID 26589907, PMID 27862048, PMID 28249145, PMID 29455932, PMID 29669226, PMID 33283990, PMID 33560399, PMID 34175041, PMID 34795208, PMID 34917079, PMID 35075288, PMID 35745672, PMID 36058507, PMID 36637054, PMID 36690839, PMID 37975597, PMID 39722321, PMID 39891377, PMID 40010689, PMID 41871072, PMID 41931048, PMID 41984996, PMID 42233421
2014 (1), 2017 (1), R01DK055463 (1), R33HL147845 (1)